Table of Contents 3
List of Tables 5
List of Figures 5
Aptose Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Aptose Biosciences Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Aptose Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Aptose Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Aptose Biosciences Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Aptose Biosciences Inc, Pharmaceuticals & Healthcare, Deal Details 11
Private Equity 11
Aptose Biosciences to Raise up to USD20 Million in Financing 11
Partnerships 13
Aptose Biosciences Enters into Agreement with Laxai Avanti Life Sciences 13
Lorus Therapeutics Enters Into Agreement With Brock University To Develop Novel Anticancer Drugs 14
Cancer Research UK Enters Into Co-Development Agreement With Lorus To Develop Cancer Drug 15
Licensing Agreements 17
Aptose Biosciences Enters into Licensing Agreement with CrystalGenomics 17
OHM Oncology Enters into Licensing Agreement with Aptose Biosciences 18
Aptose Biosciences Enters into Licensing Agreement with CrystalGenomics 19
Equity Offering 20
Aptose Biosciences Files Shelf Prospectus to Raise up to USD100 Million in Public Offering of Shares 20
Aptose Biosciences Raises Funds through Public Offering of Shares 21
Lorus Therapeutics Completes Underwriters Exercise Of Over-Allotment Option Of Public Offering Of Shares For US$25.3 Million 22
Lorus Therapeutics Completes Underwriters' Exercise Of Over-Allotment Option For Public Offering Of Shares For US$7.7 Million 24
Lorus Therapeutics Completes Private Placement Of Units For US$0.9 Million 26
Lorus Therapeutics Completes Private Placement Of Units For US$6.6 Million 27
Aptose Biosciences Inc - Key Competitors 29
Aptose Biosciences Inc - Key Employees 30
Aptose Biosciences Inc - Locations And Subsidiaries 31
Head Office 31
Other Locations & Subsidiaries 31
Recent Developments 32
Financial Announcements 32
Nov 06, 2018: Aptose reports results for the third quarter ended september 30, 2018 32
Aug 07, 2018: Aptose reports results for the second quarter ended june 30, 2018 35
May 10, 2018: Aptose Reports Results for the First Quarter Ended March 31, 2018 37
Mar 27, 2018: Aptose Reports Results for the Fourth Quarter and Year Ended December 31, 2017 39
Nov 14, 2017: Aptose Reports Results for the Third Quarter Ended September 30, 2017 41
Aug 08, 2017: Aptose Reports Results for the Second Quarter Ended June 30, 2017 43
May 11, 2017: Aptose Reports Results for the First Quarter Ended March 31, 2017 45
Mar 28, 2017: Aptose Reports Fourth Quarter and Year End 2016 Results 47
Corporate Communications 51
Aug 15, 2018: Aptose Biosciences appoints Carol Ashe as Board Director 51
Apr 25, 2018: Aptose Names Caroline M. Loewy As Board Director 52
Mar 27, 2017: Aptose Announces Planned Departure of Chief Business Officer 53
Legal and Regulatory 54
Feb 07, 2018: Aptose Biosciences Files New Preliminary Base Shelf Prospectus to Replace Expired Base Prospectus 54
Product Approvals 55
Jun 29, 2018: FDA Lifts Clinical Hold so MYC Inhibitor APTO-253 Can Return to Phase 1b Trial In Patients With Hematologic Cancers 55
Clinical Trials 56
Jun 04, 2018: Aptose Announces Two Publications of Preclinical Data Elucidating the Anticancer Mechanism of Action of APTO-253 56
Apr 17, 2018: Aptose Presents Preclinical Data on APTO-253 at 2018 AACR Annual Meeting 57
Mar 15, 2018: Aptose to Present Preclinical Data of APTO-253 at the 2018 AACR Annual Meeting 58
Appendix 59
Methodology 59
About GlobalData 59
Contact Us 59
Disclaimer 59

List of Tables
Aptose Biosciences Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Aptose Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Aptose Biosciences Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Aptose Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Aptose Biosciences Inc, Deals By Therapy Area, 2012 to YTD 2018 9
Aptose Biosciences Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Aptose Biosciences to Raise up to USD20 Million in Financing 11
Aptose Biosciences Enters into Agreement with Laxai Avanti Life Sciences 13
Lorus Therapeutics Enters Into Agreement With Brock University To Develop Novel Anticancer Drugs 14
Cancer Research UK Enters Into Co-Development Agreement With Lorus To Develop Cancer Drug 15
Aptose Biosciences Enters into Licensing Agreement with CrystalGenomics 17
OHM Oncology Enters into Licensing Agreement with Aptose Biosciences 18
Aptose Biosciences Enters into Licensing Agreement with CrystalGenomics 19
Aptose Biosciences Files Shelf Prospectus to Raise up to USD100 Million in Public Offering of Shares 20
Aptose Biosciences Raises Funds through Public Offering of Shares 21
Lorus Therapeutics Completes Underwriters Exercise Of Over-Allotment Option Of Public Offering Of Shares For US$25.3 Million 22
Lorus Therapeutics Completes Underwriters' Exercise Of Over-Allotment Option For Public Offering Of Shares For US$7.7 Million 24
Lorus Therapeutics Completes Private Placement Of Units For US$0.9 Million 26
Lorus Therapeutics Completes Private Placement Of Units For US$6.6 Million 27
Aptose Biosciences Inc, Key Competitors 29
Aptose Biosciences Inc, Key Employees 30
Aptose Biosciences Inc, Other Locations 31

List of Figures
Aptose Biosciences Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Aptose Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Aptose Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Aptose Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Aptose Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Aptose Biosciences Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
Aptose Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Aptose Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9